SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-021396
Filing Date
2024-03-11
Accepted
2024-03-11 16:05:37
Documents
15
Period of Report
2024-03-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea0201543-8k_10xcap3.htm   iXBRL 8-K 29900
  Complete submission text file 0001213900-24-021396.txt   260234

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE vcxb-20240311.xsd EX-101.SCH 4221
3 XBRL DEFINITION FILE vcxb-20240311_def.xml EX-101.DEF 27375
4 XBRL LABEL FILE vcxb-20240311_lab.xml EX-101.LAB 38062
5 XBRL PRESENTATION FILE vcxb-20240311_pre.xml EX-101.PRE 25995
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0201543-8k_10xcap3_htm.xml XML 7694
Mailing Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007
Business Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007 (212) 257-0069
10X Capital Venture Acquisition Corp. III (Filer) CIK: 0001848948 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41216 | Film No.: 24737974
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)